// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Early UK experience of referred cases of possible silicosis following updated guidance on silica healthsurveillance

David Fishwick - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impaired Alveolar Macrophage Efferocytosis in ARDS causes accumulation of apoptotic neutrophils & prolonged inflammation

Rahul Mahida - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Sepsis

N/A

Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity?

Abdi Ali - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Rhinosinusitis is associated with increased symptoms and more frequent exacerbations among patients with bronchiectasis- data from the EMBARC registry

Michal Shteinberg - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cross-site external biological control (BioQC) in cardiopulmonary exercise testing (CPET) equipment.

Courtney Dos Santos - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Reduction of COPD exacerbations with extrafine single inhaler triple therapy: post-hoc analysis by exacerbation treatment of the TRIBUTE study

Leonardo Fabbri - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Care in the Last Days of Life and Carer Perspectives

Ahmed Haque - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of inhaled 19F C3F8 and hyperpolarized 129Xe lung ventilation MRI

Adam Maunder - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Exacerbation outcomes with LAMA/LABA and ICS/LABA in high risk COPD patients in the IMPACT trial

David A Lipson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

fluticasone furoate/umeclidinium/vilanterol

An evaluation of ‘care bundles’ as a means of improving hospital care for patients with COPD: results of a multi-centre study in the UK

James Calvert - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Remote monitoring of home non-invasive ventilation: a feasibility study

Julie Young - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A novel piperidine attenuates pulmonary arterial hypertension via regulating BMP2 and PTGS2 levels

Yanjiang Xing - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Cross-sectional comparison of the bronchiectasis-specific quality of life questionnaires

Arietta Spinou - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Late Breaking Abstract - Gender and asthma: Gender-dependent effects of obesity on allergic pulmonary inflammation

Rodrigo Lacerda - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Obesity

N/A

Incidence and risk factors of pediatric asthma exacerbations in a multinational, multidatabase cohort study

Esm J. Baan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Late Breaking Abstract - Intra-alveolar neutrophil-derived microvesicles: a biomarker of COPD severity

Justin Garner - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Prognostic value of using FeNO to guide step-down treatment decisions in asthma

Kay Wang - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Validation of the King’s Brief Interstitial Lung Disease questionnaire in Danish

Thomas Skovhus Prior - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Disease progression patterns in COPD

Felix John Samuel Bragman - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Patient-reported side effects of oral corticosteroids

Catherine Broadbent - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved